NATIVE CARDIO, INC.

Profile

Company Names

NATIVE CARDIO, INC.

Addresses

868 106TH AVENUE N, SUITE 8, NAPLES, FL 34108

Phone Numbers

239-597-3564

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$3,115,241.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-02-25 
$150,000.00 
$1,000,000.00 
$850,000.00 
 
2
2021-05-06 
$465,000.00 
$5,000,000.00 
$4,535,000.00 
Debt 
1
2019-02-08 
$2,500,241.00 
$6,000,000.00 
$3,499,759.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTINE 
MIKAIL 
CVIJIC 
DIRECTOR
NEUMENTUM, INC.   |  NATIVE CARDIO, INC.   |  NEUROGENE INC.
MYLES 
P. 
DEMPSEY, SR. 
DIRECTOR
NATIVE CARDIO, INC.
GARY 
 
DIXON 
EXECUTIVE OFFICER
NATIVE CARDIO, INC.
PEDRO 
 
GRANADILLO 
DIRECTOR
NILE THERAPEUTICS, INC.   |  AURA BIOSCIENCES, INC.   |  NEUMENTUM, INC.   |  NATIVE CARDIO, INC.
YOUNG 
D. 
KIM 
DIRECTOR
NATIVE CARDIO, INC.
JOSEPH 
V. 
PERGOLIZZI 
EXECUTIVE OFFICER, DIRECTOR
NATIVE CARDIO, INC.
JOSEPH 
V. 
PERGOLIZZI, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NATIVE CARDIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-03-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2025-02-25 
2023-03-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-05-06 
2021-05-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-05-06 
2021-01-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-08 
2020-01-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-08 
2019-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CORINTHIAN PARTNERS LLC
38912
THEODORE KALEM
2261915
CIM SECURITIES, LLC
120852
JOHN G. MYERS
2544310